Dr. Sharon Hausman-Cohen: How to Address Dementia, Autism, and Other Chronic Diseases with Genomic Testing

View the Show Notes For This Episode

Get Free Weekly Health Tips from Dr. Hyman

Sign Up for Dr. Hyman’s Weekly Longevity Journal

Get Ad-free Episodes & Dr. Hyman+ Audio Exclusives

Dr. Sharon Hausman-Cohen is the Chief Medical Officer and co-founder of IntellxxDNA and has been in the field of integrative medicine for over 25 years. She is the co-author of many publications and a textbook chapter on using genomics to improve outcomes in cognitive decline and autism.

This episode is brought to you by Rupa Health, Fatty15, BiOptimizers, and ARMRA.

Streamline your lab orders with Rupa Health. Access more than 3,000 specialty lab tests and register for a FREE live demo at RupaHealth.com.

Fatty15 contains pure, award-winning C15:0 in a bioavailable form. Get an exclusive 10% off a 90-day starter kit subscription. Just visit Fatty15.com and use code DRHYMAN10 to get started.

Tackle an overlooked root cause of stress with Magnesium Breakthrough. Visit bioptimizers.com/hyman and use code HYMAN10 to save 10% and receive free gifts with your purchase.

Save 15% on your first order of ARMRA Colostrum and unlock the power of 400+ functional nutrients. Just visit TryARMRA.com/Mark or use code MARK.

In this episode we discuss (audio version / Apple Subscriber version):

What are genes and what do they do? (6:37 / 4:33)

Genetic predisposition does not mean predestined (9:22 / 7:18)

The difference between genetics vs genomics (13:10 / 11:06)

Polygenic risk scoring for chronic disease (18:18 / 16:14)

Dementia risk and treatment (33:59 / 29:24)

Mental and cognitive health issues in children (46:00 / 41:25)

The similarities between Autism and Alzheimer’s patients (49:49 / 45:14)

My genomic test results, specifically related to detoxification and osteoporosis (52:21 / 47:45)

Genetic vs genomic testing (1:06:29 / 1:01:54)

Learn more at IntellxxDNA.com.

Learn more about your ad choices. Visit megaphone.fm/adchoices